SCHEMBL6038314

SCHEMBL6038314

O=C(COCc1ccc(F)cc1)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.58
TSHR P16473 4/20 0.55
LMNA P02545 3/20 0.55
BLM P54132 3/20 0.55
CYP3A4 P08684 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HTR1A P08908 1/20 0.55
NFKB1 P19838 1/20 0.55
CNR1 P21554 1/20 0.55
ADRA1A P35348 1/20 0.55
ABCC8 Q09428 2/20 0.53
ALDH1A1 P00352 2/20 0.53
KCNH2 Q12809 2/20 0.53
MEN1 O00255 1/20 0.53
ABCC3 O15438 1/20 0.53
ABCC4 O15439 1/20 0.53
ABCC9 O60706 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284801 0.83 ALDH1A1 (0.51) LMNACYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL28407544 0.82 ATM (0.76) PPARGTSHRLMNABLMCYP3A4
SCHEMBL28407181 0.80 PPARG (0.76) PPARGTSHRLMNABLMCYP3A4
SCHEMBL11874263 0.78 PPARG (0.69) PPARGTSHRLMNABLMCYP3A4
SCHEMBL2631551 0.77 PPARG (0.81) PPARGTSHRLMNABLMCYP3A4
SCHEMBL6038200 0.77 CA1 (0.71) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL12869021 0.76 PPARG (0.67) PPARGTSHRLMNABLMCYP3A4
SCHEMBL12857011 0.76 PPARG (0.67) PPARGTSHRLMNABLMCYP3A4
SCHEMBL28465800 0.76 PPARG (0.63) PPARGTSHRLMNABLMCYP3A4
SCHEMBL9102046 0.74 PPARG (0.69) PPARGTSHRLMNABLMCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 PPARG 2151/4885TSHR 2191/4885LMNA 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.